| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
215255 |
001 |
ANDA |
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN |
TABLET, EXTENDED RELEASE |
1000MG |
No
|
No
|
2025/10/01
(TA)
|
--
|
MACLEODS PHARMACEUTICALS LTD |
None (Tentative Approval) |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
215255 |
002 |
ANDA |
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN |
TABLET, EXTENDED RELEASE |
50MG |
No
|
No
|
2025/10/01
(TA)
|
--
|
MACLEODS PHARMACEUTICALS LTD |
None (Tentative Approval) |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
215255 |
003 |
ANDA |
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN |
TABLET, EXTENDED RELEASE |
150MG |
No
|
No
|
2025/10/01
(TA)
|
--
|
MACLEODS PHARMACEUTICALS LTD |
None (Tentative Approval) |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
215255 |
004 |
ANDA |
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN |
TABLET, EXTENDED RELEASE |
500MG |
No
|
No
|
2025/10/01
(TA)
|
--
|
MACLEODS PHARMACEUTICALS LTD |
None (Tentative Approval) |